Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Petroula Proitsi

Showing results (41-50 of 93) with videos related to

Pageof 10
Sort By:
Alzheimer'S Research & Therapy|January 9, 2021
Association between polygenic risk score of Alzheimer's disease and plasma phosphorylated tau in individuals from the Alzheimer's Disease Neuroimaging InitiativeAnna Zettergren, Jodie Lord, Nicholas J Ashton, et al.
Scientific Reports|December 5, 2015
Lipidomics comparing DCD and DBD liver allografts uncovers lysophospholipids elevated in recipients undergoing early allograft dysfunctionJin Xu, Ana M Casas-Ferreira, Yun Ma, et al.
Plos One|June 14, 2013
Inflammatory proteins in plasma are associated with severity of Alzheimer's diseaseRufina Leung, Petroula Proitsi, Andrew Simmons, et al.
Translational Neurodegeneration|September 21, 2020
Integrated lipidomics and proteomics network analysis highlights lipid and immunity pathways associated with Alzheimer's diseaseJin Xu, Giulia Bankov, Min Kim, et al.
Journal of Alzheimer'S Disease : JAD|October 11, 2012
Entorhinal cortex thickness predicts cognitive decline in Alzheimer's diseaseLatha Velayudhan, Petroula Proitsi, Eric Westman, et al.
Medrxiv : the Preprint Server for Health Sciences|May 18, 2026
Polyol pathway dysregulation in CSF links glucose metabolism to tau pathology independently of amyloid and genetic predispositionMarc Clos-Garcia, Asger Wretlind, Tik Muk, et al.
Journal of Alzheimer'S Disease : JAD|October 6, 2011
Combinatorial markers of mild cognitive impairment conversion to Alzheimer's disease--cytokines and MRI measures together predict disease progressionSimon J Furney, Deborah Kronenberg, Andrew Simmons, et al.
Neurobiology of Aging|September 18, 2013
Evidence of altered phosphatidylcholine metabolism in Alzheimer's diseaseLuke Whiley, Arundhuti Sen, James Heaton, et al.
Neurobiology of Aging|September 26, 2013
Alzheimer's disease susceptibility variants in the MS4A6A gene are associated with altered levels of MS4A6A expression in bloodPetroula Proitsi, Sang Hyuck Lee, Katie Lunnon, et al.
Alzheimer'S Research & Therapy|July 16, 2026
Steroid hormones in Alzheimer's disease: a molecular analysis of blood and cerebrospinal fluidTik Muk, Asger Wretlind, Kourosh Hooshmand, et al.
Pageof 10

Showing results (41-50 of 93) with videos related to

Sort By:
Pageof 10
Alzheimer'S Research & Therapy|January 9, 2021
Association between polygenic risk score of Alzheimer's disease and plasma phosphorylated tau in individuals from the Alzheimer's Disease Neuroimaging InitiativeAnna Zettergren, Jodie Lord, Nicholas J Ashton, et al.
Scientific Reports|December 5, 2015
Lipidomics comparing DCD and DBD liver allografts uncovers lysophospholipids elevated in recipients undergoing early allograft dysfunctionJin Xu, Ana M Casas-Ferreira, Yun Ma, et al.
Plos One|June 14, 2013
Inflammatory proteins in plasma are associated with severity of Alzheimer's diseaseRufina Leung, Petroula Proitsi, Andrew Simmons, et al.
Translational Neurodegeneration|September 21, 2020
Integrated lipidomics and proteomics network analysis highlights lipid and immunity pathways associated with Alzheimer's diseaseJin Xu, Giulia Bankov, Min Kim, et al.
Journal of Alzheimer'S Disease : JAD|October 11, 2012
Entorhinal cortex thickness predicts cognitive decline in Alzheimer's diseaseLatha Velayudhan, Petroula Proitsi, Eric Westman, et al.
Medrxiv : the Preprint Server for Health Sciences|May 18, 2026
Polyol pathway dysregulation in CSF links glucose metabolism to tau pathology independently of amyloid and genetic predispositionMarc Clos-Garcia, Asger Wretlind, Tik Muk, et al.
Journal of Alzheimer'S Disease : JAD|October 6, 2011
Combinatorial markers of mild cognitive impairment conversion to Alzheimer's disease--cytokines and MRI measures together predict disease progressionSimon J Furney, Deborah Kronenberg, Andrew Simmons, et al.
Neurobiology of Aging|September 18, 2013
Evidence of altered phosphatidylcholine metabolism in Alzheimer's diseaseLuke Whiley, Arundhuti Sen, James Heaton, et al.
Neurobiology of Aging|September 26, 2013
Alzheimer's disease susceptibility variants in the MS4A6A gene are associated with altered levels of MS4A6A expression in bloodPetroula Proitsi, Sang Hyuck Lee, Katie Lunnon, et al.
Alzheimer'S Research & Therapy|July 16, 2026
Steroid hormones in Alzheimer's disease: a molecular analysis of blood and cerebrospinal fluidTik Muk, Asger Wretlind, Kourosh Hooshmand, et al.
Pageof 10